Terms: = Thyroid cancer AND NTRK3, TRKC, 4916, ENSG00000140538, Q16288, gp145 trkC
87 results:
1. [Stratified application of gene expression in diagnosis of thyroid nodules].
Guan WY; Zheng JY; Nie L; Wu HY
Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):264-268. PubMed ID: 38433054
[No Abstract] [Full Text] [Related]
2. Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland.
Zhang W; Schmitz AA; Kallionpää RE; Perälä M; Pitkänen N; Tukiainen M; Alanne E; Jöhrens K; Schulze-Rath R; Farahmand B; Zong J
Oncotarget; 2024 Feb; 15():106-116. PubMed ID: 38329731
[TBL] [Abstract] [Full Text] [Related]
3. Macrofollicular Architecture in Invasive Encapsulated Follicular Variant of Papillary thyroid Carcinoma: A Pitfall in thyroid Practice.
Yadav S; Kandasamy D; Damle N; Goel R; Chumber S; Sharma MC; Boruah M; Agarwal S
Head Neck Pathol; 2023 Dec; 17(4):899-909. PubMed ID: 37775618
[TBL] [Abstract] [Full Text] [Related]
4. A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary thyroid Carcinoma.
Chou A; Qiu MR; Crayton H; Wang B; Ahadi MS; Turchini J; Clarkson A; Sioson L; Sheen A; Singh N; Clifton-Bligh RJ; Robinson BG; Gild ML; Tsang V; Leong D; Sidhu SB; Sywak M; Delbridge L; Aniss A; Wright D; Graf N; Kumar A; Rathi V; Benitez-Aguirre P; Glover AR; Gill AJ
Mod Pathol; 2023 Dec; 36(12):100329. PubMed ID: 37716505
[TBL] [Abstract] [Full Text] [Related]
5. Nodal Metastases Associated With Fusion Oncogenes Are Age Dependent in Young Adult Patients With thyroid cancer.
Li H; Han R; Meng L; Sun Y; Zhao M; Zhou W; Xie J; Yu D; Shen L; Zhou Y; Wang S; Yan J; Wang W; Ye L
J Clin Endocrinol Metab; 2023 Dec; 109(1):143-150. PubMed ID: 37536280
[TBL] [Abstract] [Full Text] [Related]
6. Identification of Chimeric ntrk3 Genes in Papillary thyroid cancer Cells by Analyzing the Imbalance of the Expression of 5' and 3' mRNA Fragments.
Oskorbin IP; Ivanov AA; Smertina MA; Demidova IA; Boyarskikh UA; Kechin AA; Bakharev SY; Samuilenkova OV; Vihlyanov IV; Kushlinskii NE; Filipenko ML
Bull Exp Biol Med; 2023 Jun; 175(2):239-244. PubMed ID: 37477743
[TBL] [Abstract] [Full Text] [Related]
7. NTRK fusions in solid tumours: what every pathologist needs to know.
Nguyen MA; Colebatch AJ; Van Beek D; Tierney G; Gupta R; Cooper WA
Pathology; 2023 Aug; 55(5):596-609. PubMed ID: 37330338
[TBL] [Abstract] [Full Text] [Related]
8. A Shift in Molecular Drivers of Papillary thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases.
Hang JF; Chen JY; Kuo PC; Lai HF; Lee TL; Tai SK; Kuo CS; Chen HS; Li WS; Li CF
Mod Pathol; 2023 Sep; 36(9):100242. PubMed ID: 37307878
[TBL] [Abstract] [Full Text] [Related]
9. Molecular and Cytogenetic Features of NTRK Fusions Enriched in BRAF and RET Double-Negative Papillary thyroid cancer.
Wu S; Liu Y; Li K; Liang Z; Zeng X
J Mol Diagn; 2023 Aug; 25(8):569-582. PubMed ID: 37236546
[TBL] [Abstract] [Full Text] [Related]
10. Molecular and clinical features of papillary thyroid cancer in adult patients with a non-classical phenotype.
Zhou J; Wang WR; Zhang HF; Gao QQ; Wang WB; Zhu JH; Han YS; Chen J; Ma TH; Zhang XY; Teng XD
Front Endocrinol (Lausanne); 2023; 14():1138100. PubMed ID: 37124750
[TBL] [Abstract] [Full Text] [Related]
11. NTRK Fusion in a Cohort of BRAF p. V600E Wild-Type Papillary thyroid Carcinomas.
Lee SE; Lee MS; Bang H; Kim MY; Choi YL; Oh YL
Mod Pathol; 2023 Aug; 36(8):100180. PubMed ID: 37003481
[TBL] [Abstract] [Full Text] [Related]
12. Entrectinib in the neoadjuvant setting of anaplastic thyroid cancer: a case report.
Damásio I; Simões-Pereira J; Donato S; Horta M; Cavaco BM; Rito M; Gomes P; Leite V
Eur Thyroid J; 2023 Feb; 12(1):. PubMed ID: 36378538
[TBL] [Abstract] [Full Text] [Related]
13. Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis.
Han M; Wang Y; Jin Y; Zhao X; Cui H; Wang G; Gang X
Front Endocrinol (Lausanne); 2022; 13():984593. PubMed ID: 36313770
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathological significance of major fusion oncogenes in papillary thyroid carcinoma: An individual patient data meta-analysis.
Vuong HG; Le HT; Le TTB; Le T; Hassell L; Kakudo K
Pathol Res Pract; 2022 Dec; 240():154180. PubMed ID: 36306725
[TBL] [Abstract] [Full Text] [Related]
15. Nefarious NTRK oncogenic fusions in pediatric sarcomas: Too many to Trk.
Aepala MR; Peiris MN; Jiang Z; Yang W; Meyer AN; Donoghue DJ
Cytokine Growth Factor Rev; 2022 Dec; 68():93-106. PubMed ID: 36153202
[TBL] [Abstract] [Full Text] [Related]
16. Limited Accuracy of Pan-Trk Immunohistochemistry Screening for
Macerola E; Proietti A; Poma AM; Vignali P; Sparavelli R; Ginori A; Basolo A; Elisei R; Santini F; Basolo F
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806472
[TBL] [Abstract] [Full Text] [Related]
17. Prediction of EVT6-ntrk3-Dependent Papillary thyroid cancer Using Minor Expression Profile.
Kechin AA; Ivanov AA; Kel AE; Kalmykov AS; Oskorbin IP; Boyarskikh UA; Kharpov EA; Bakharev SY; Oskina NA; Samuilenkova OV; Vikhlyanov IV; Kushlinskii NE; Filipenko ML
Bull Exp Biol Med; 2022 Jun; 173(2):252-256. PubMed ID: 35737155
[TBL] [Abstract] [Full Text] [Related]
18. [Clinicopathological features of ntrk3 gene rearrangement papillary thyroid carcinoma].
Li HQ; Chen XY; Yu XB; Chen LY; Zhang X; Jin L; Wu ZZ; Chen Z
Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):126-131. PubMed ID: 35152631
[No Abstract] [Full Text] [Related]
19. Fusion Oncogenes Are Associated With Increased Metastatic Capacity and Persistent Disease in Pediatric thyroid cancers.
Franco AT; Ricarte-Filho JC; Isaza A; Jones Z; Jain N; Mostoufi-Moab S; Surrey L; Laetsch TW; Li MM; DeHart JC; Reichenberger E; Taylor D; Kazahaya K; Adzick NS; Bauer AJ
J Clin Oncol; 2022 Apr; 40(10):1081-1090. PubMed ID: 35015563
[TBL] [Abstract] [Full Text] [Related]
20. Unique Molecular Signatures Are Associated with Aggressive Histology in Pediatric Differentiated thyroid cancer.
Mollen KP; Shaffer AD; Yip L; Monaco SE; Huyett P; Viswanathan P; Witchel SF; Duvvuri U; Simons JP
Thyroid; 2022 Mar; 32(3):236-244. PubMed ID: 34915753
[No Abstract] [Full Text] [Related]
[Next]